Kristen Tecson to Risk Factors
This is a "connection" page, showing publications Kristen Tecson has written about Risk Factors.
Connection Strength
0.058
-
Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation. J Am Heart Assoc. 2018 05 17; 7(11).
Score: 0.023
-
Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 Syndrome. J Am Heart Assoc. 2020 11 17; 9(22):e017364.
Score: 0.007
-
Cardiorenal Outcomes in the CANVAS, DECLARE-TIMI 58, and EMPA-REG OUTCOME Trials: A Systematic Review. Rev Cardiovasc Med. 2018 Jun 30; 19(2):41-49.
Score: 0.006
-
Inhibition of the Sodium-Proton Antiporter (Exchanger) is a Plausible Mechanism of Potential Benefit and Harm for Drugs Designed to Block Sodium Glucose Co-transporter 2. Rev Cardiovasc Med. 2018 Jun 30; 19(2):51-63.
Score: 0.006
-
Prognostic value of urinary 11-dehydro-thromboxane B2 for mortality: A cohort study of stable coronary artery disease patients treated with aspirin. Catheter Cardiovasc Interv. 2018 10 01; 92(4):653-658.
Score: 0.006
-
Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease. Coron Artery Dis. 2017 Jun; 28(4):287-293.
Score: 0.005
-
Balancing Low-density Lipoprotein Cholesterol Reduction and Hepatotoxicity With Lomitapide Mesylate and Mipomersen in Patients With Homozygous Familial Hypercholesterolemia. Rev Cardiovasc Med. 2017; 18(1):21-28.
Score: 0.005